Max Healthcare Institute Limited
Символ: MAXHEALTH.NS
NSE
734.85
INRПазарна цена днес
73.8463
Съотношение P/E
0.1498
Коефициент PEG
714.17B
MRK Cap
- 0.00%
Доходност на DIV
Max Healthcare Institute Limited (MAXHEALTH-NS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 65841.7 | 14986.1 | 4864.2 | 6267.9 | ||||||||||
balance-sheet.row.short-term-investments | 82197.9 | 14558.6 | 1772.8 | 2 | ||||||||||
balance-sheet.row.net-receivables | 7989.4 | 3519 | 4309.3 | 4259.7 | ||||||||||
balance-sheet.row.inventory | 1477.9 | 762.3 | 613.6 | 538 | ||||||||||
balance-sheet.row.other-current-assets | 378.2 | 163.3 | 215.8 | 179.1 | ||||||||||
balance-sheet.row.total-current-assets | 75687.2 | 19430.7 | 10002.9 | 11244.7 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 45479.4 | 22256.3 | 20583.2 | 17749.1 | ||||||||||
balance-sheet.row.goodwill | 49093.2 | 24546.6 | 24546.6 | 24546.6 | ||||||||||
balance-sheet.row.intangible-assets | 52135.5 | 26108.4 | 26557.3 | 23337.4 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 101228.7 | 50655 | 51103.9 | 47884 | ||||||||||
balance-sheet.row.long-term-investments | -351.8 | 5.1 | 20.2 | 10.4 | ||||||||||
balance-sheet.row.tax-assets | 11234.5 | 5430.4 | 10181.2 | 9.8 | ||||||||||
balance-sheet.row.other-non-current-assets | -25696.2 | 3241 | -0.1 | 8546.4 | ||||||||||
balance-sheet.row.total-non-current-assets | 131894.6 | 81587.8 | 81888.4 | 74199.7 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 207581.8 | 101018.5 | 91891.3 | 85444.4 | ||||||||||
balance-sheet.row.account-payables | 11464.9 | 5434.6 | 4520.8 | 4356.9 | ||||||||||
balance-sheet.row.short-term-debt | 1571.1 | 845 | 1138 | 877.4 | ||||||||||
balance-sheet.row.tax-payables | 26.8 | 26.8 | 0 | 0.5 | ||||||||||
balance-sheet.row.long-term-debt-total | 11920.4 | 6044.6 | 10188.7 | 12375.2 | ||||||||||
Deferred Revenue Non Current | 4155.7 | 117.3 | 108.2 | 114.1 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 9037.2 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 1809.9 | 846.8 | 725.5 | 654 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 33229.7 | 16466.9 | 21493.9 | 21288.3 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 2545.1 | 1241.4 | 4060.2 | 4063 | ||||||||||
balance-sheet.row.total-liab | 55025.7 | 26922.6 | 29066.6 | 29057.6 | ||||||||||
balance-sheet.row.preferred-stock | 73630.6 | 73630.6 | 0 | 56121.7 | ||||||||||
balance-sheet.row.common-stock | 19425 | 9709.2 | 9696.1 | 9659.5 | ||||||||||
balance-sheet.row.retained-earnings | 12340.6 | 12340.6 | 1476.1 | -4585.9 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 221765.8 | 465.3 | 275.5 | 265.1 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | -22049.8 | -22049.8 | 51377 | -5073.6 | ||||||||||
balance-sheet.row.total-stockholders-equity | 305112.2 | 74095.9 | 62824.7 | 56386.8 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 360137.9 | 101018.5 | 91891.3 | 85444.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 305112.2 | 74095.9 | 62824.7 | 56386.8 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 360137.9 | - | - | - | ||||||||||
Total Investments | 69347.8 | 2065.4 | 20.2 | 10.4 | ||||||||||
balance-sheet.row.total-debt | 13491.5 | 6889.6 | 11326.7 | 13252.6 | ||||||||||
balance-sheet.row.net-debt | 29847.7 | 6462.1 | 8235.3 | 6986.7 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 10570.2 | 10637.2 | 7389 | -686.5 | ||||||||||
cash-flows.row.depreciation-and-amortization | 2350.1 | 2321.9 | 2211.2 | 1740.9 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | -1789 | -1469.1 | 549.9 | ||||||||||
cash-flows.row.stock-based-compensation | 343.6 | 343.5 | 339.3 | 265.1 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 806.4 | -1319.6 | -3762.5 | ||||||||||
cash-flows.row.account-receivables | 0 | 647.4 | 29.1 | 560.6 | ||||||||||
cash-flows.row.inventory | 0 | -148.7 | -75.6 | 172.5 | ||||||||||
cash-flows.row.account-payables | 0 | 987.4 | -447.8 | -4779 | ||||||||||
cash-flows.row.other-working-capital | 0 | -679.7 | -825.3 | 283.4 | ||||||||||
cash-flows.row.other-non-cash-items | -10913.8 | -228.2 | 334.1 | 3071.7 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 3836.8 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3356.1 | -5613.1 | -1184.2 | ||||||||||
cash-flows.row.acquisitions-net | 0 | -4.8 | -1071.6 | 16.2 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | -10757.7 | -1711.9 | 0 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 997.1 | 2783.5 | 0 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 1251.4 | -2104.6 | 438 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -11870.1 | -7717.7 | -730 | ||||||||||
cash-flows.row.debt-repayment | 0 | -1398.8 | -2496 | -8326.3 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 13.1 | 36.6 | 11791.6 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.other-financing-activites | 0 | -1499.9 | -482.3 | -1552 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -2885.6 | -2941.7 | 1913.3 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 2793.9 | ||||||||||
cash-flows.row.net-change-in-cash | 3836.8 | -2663.9 | -3174.5 | 5155.8 | ||||||||||
cash-flows.row.cash-at-end-of-period | 40896 | 427.5 | 3091.4 | 6265.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 37059.2 | 3091.4 | 6265.9 | 1110.1 | ||||||||||
cash-flows.row.operating-cash-flow | 3836.8 | 12091.8 | 7484.9 | 1178.6 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -3356.1 | -5613.1 | -1184.2 | ||||||||||
cash-flows.row.free-cash-flow | 3836.8 | 8735.7 | 1871.8 | -5.6 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 52010.9 | 45626 | 38831.9 | 24824.1 | ||||||||||
income-statement-row.row.cost-of-revenue | 8689.9 | 9220.1 | 9229 | 5944.1 | ||||||||||
income-statement-row.row.gross-profit | 43321 | 36405.9 | 29602.9 | 18880 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 3.6 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 10863.4 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 575.5 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | -608.1 | 268.6 | 109.6 | 100 | ||||||||||
income-statement-row.row.operating-expenses | 29127.2 | 26322.5 | 21848.4 | 16040.8 | ||||||||||
income-statement-row.row.cost-and-expenses | 37817.1 | 35542.6 | 31077.4 | 21984.9 | ||||||||||
income-statement-row.row.interest-income | 1520.4 | 1123.8 | 750.9 | 767.3 | ||||||||||
income-statement-row.row.interest-expense | 586.9 | 838.6 | 900.1 | 1710 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 575.5 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | -173.7 | 397 | -190.6 | -3347.5 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | -608.1 | 268.6 | 109.6 | 100 | ||||||||||
income-statement-row.row.total-operating-expenses | -173.7 | 397 | -190.6 | -3347.5 | ||||||||||
income-statement-row.row.interest-expense | 586.9 | 838.6 | 900.1 | 1710 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 2350.1 | 2321.9 | 2211.2 | 1740.9 | ||||||||||
income-statement-row.row.ebitda-caps | 16239.7 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 13476.4 | 10240.2 | 7579.6 | 2430.5 | ||||||||||
income-statement-row.row.income-before-tax | 13302.7 | 10637.2 | 7389 | -686.5 | ||||||||||
income-statement-row.row.income-tax-expense | 2732.5 | -397.9 | 1338.5 | 458.5 | ||||||||||
income-statement-row.row.net-income | 10570.2 | 11035.1 | 6050.5 | -1375.5 |
Често задавани въпроси
Какво е Max Healthcare Institute Limited (MAXHEALTH.NS) общи активи?
Max Healthcare Institute Limited (MAXHEALTH.NS) общите активи са 101018500000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 26981300000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 3.948.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 3.948.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.203.
Какъв е общият приход на предприятието?
Общият приход е 0.259.
Каква е Max Healthcare Institute Limited (MAXHEALTH.NS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 11035100000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 6889600000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 26322500000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са -17918800000.000.